Professor, Mayo Clinic – Rochester, MN
The research interests of Dusica Babovic-Vuksanovic, M.D., include overgrowth syndromes, as well as various genetic syndromes and metabolic disorders. Her research involves several collaborative basic research studies in the field of neurofibromatosis, in conjunction with Mayo’s Neuro-Oncology Program and departments of Radiology and Neurologic Surgery.
- Neurofibromatosis. Dr. Babovic-Vuksanovic holds a leadership role in collaborative studies looking at children, adolescents and young adults with neurofibromatosis 1 and progressive plexiform neurofibromas as well as adult patients with neurofibromatosis 1 and extensive plexiform and paraspinal neurofibromas.
- Spontaneous coronary artery dissection (SCAD). Dr. Babovic-Vuksanovic is part of a multidisciplinary team carrying out patient-initiated research regarding SCAD, a nonatherosclerotic abnormality of the heart artery in which obstruction of blood flow to the heart occurs due to splitting of the vessel walls.
Michael J. Fisher, MD
Director of the Neurofibromatosis Program at Children’s Hospital of Philadelphia
Michael J. Fisher, MD, is chief of the Section of Neuro-Oncology in the Cancer Center at The Children’s Hospital of Philadelphia and director of the Neuro-Oncology Fellowship Program. He has a special interest in brain tumors and neurofibromatosis. After graduating from Harvard Medical School, he did his pediatric training at Children’s Hospital in Boston. He then did fellowships in pediatric hematology/oncology and pediatric neuro-oncology at CHOP, and has been on staff at CHOP since that time.
- Identifying new treatments and novel biomarkers (particularly using new imaging modalities)
- Exploring functional outcomes for children with tumors associated with NF1 and for brain tumors.